Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Sagard Capital Partners, L.P. and Jaguar Health Inc. (JAGX)

Page 1 of 25

Jaguar Health Inc. (NASDAQ:JAGX): Dan Friedberg’s Sagard Capital Partners, L.P. filed an amended 13D.

You can check out Sagard Capital Partners, L.P.’s latest holdings and filings here.

Please follow Sagard Capital Partners, L.P. (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Sagard Capital Partners, L.P. or update its stock holdings.

Dan Friedberg
Dan Friedberg
Sagard Capital Partners Management Corp

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Sagard Capital Partners 0 49,724,330 0 49,724,330 49,724,330 22.6%
Sagard Capital Partners GP, Inc 0 49,724,330 0 49,724,330 49,724,330 22.6%
Sagard Capital Partners Management Corp 0 49,724,330 0 49,724,330 49,724,330 22.6%

Page 1 of 25 – SEC Filing

 

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

 

 

 

SCHEDULE 13D

 

 

Under the Securities Exchange Act of 1934
(Amendment No.     )*

 

JAGUAR HEALTH, INC.

(Name of Issuer)

 

Common Stock, $0.0001 par value

(Title Class of Securities)

 

47010C201

(CUSIP Number)

 

Samuel Robinson

Sagard Capital Partners, L.P.

280 Park Avenue, 3rd Floor West

New York, NY 10017

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

March 23, 2018

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box o.

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 


Follow Jaguar Health Inc. (NASDAQ:JAGX)
Trade (NASDAQ:JAGX) Now!
Page 1 of 25
Loading...